Status:
COMPLETED
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Anemia (Iron-Loading)
Beta-Thalassemia
Eligibility:
All Genders
5+ years
Phase:
PHASE2
Brief Summary
To determine whether deferoxamine prevented the complications of transfusional iron overload.
Detailed Description
BACKGROUND: The prognosis of congenital or long-term anemia was formerly limited by the complications of blood transfusion, splenectomy, or infection, problems now largely overcome by sophisticated c...
Eligibility Criteria
Males and females, 5 years or older, with transfusional hemochromatosis.
Key Trial Info
Start Date :
January 1 1978
Trial Type :
INTERVENTIONAL
End Date :
September 1 1994
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000595
Start Date
January 1 1978
End Date
September 1 1994
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.